increase of the registered capital of the Company by issuing 650,789,079 newly issued ordinary shares with a par value of Baht 1. 00 per share accounting for 18. 48 percent the Company’ s issued and paid- up
increase of the registered capital of the Company by issuing 650,789,079 newly issued ordinary shares with a par value of Baht 1. 00 per share accounting for 18. 48 percent the Company’ s issued and paid- up
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
% (620,591) (1,261,868) 51% Basic Earnings (Loss) per share Loss (Baht per share) (0.0073) (0.0762) -90% (0.0273) (0.0827) -67% Weighted average number of common shares (Thousand shares) 22,740,610 15,257,471
the same period of 2019. Administrative Expenses In the 2nd Quarter of 2018 and 2019, administration costs increased from THB 105.0 Mn to THB 117.9 Mn respectively, an increase of THB 12.9 Mn or 12.3
period of 2019. This increase was mainly due to switching towards more cost-effective marketing channels. Administrative Expenses In the 3rd Quarter of 2018 and 2019, administration costs increased from
reduction of 89,200,714 unissued shares of the Company at a par value of Baht 1.00 per share, reserved for the exercise of warrants to purchase ordinary shares no. 1, issued and offered to the existing
capital by Baht 89,200,714 from the existing Baht 259,250,000 to Baht 170,049,286, by means of reduction of 89,200,714 unissued shares of the Company at a par value of Baht 1.00 per share, reserved for the
14,195.4 13,797.5 +2.9% 12,448.8 +10.8% [ Sales Revenue, USD $420.4 $394.0 +6.7% $364.9 +7.9% ] Cost of Sales 9,933.1 8,985.0 8,535.0 Gross margin, (%) 30.0% 34.9% 31.4% Selling&Administration 1,817.6
shows a higher gross profit margin than other businesses of the group. However, the group began to recognize revenue since January 2017 at the generating capacity of 16.47 MW. Selling and administration